Five genes associated with the prognosis of glioma (ECI2, MCCC2, OXCT1, SUCLG2, and CPT2) were revealed and then, validated using glioma tissues, providing novel insights into individualized treatment and prognosis. The gene discussed is SUCLG2; the disease is central nervous system cancer.